Previous Page  20 / 46 Next Page
Information
Show Menu
Previous Page 20 / 46 Next Page
Page Background

18

Contenido disponible en

www.neumologia-pediatrica.cl

2. Scully C, Limeres J, Gleeson M, I. T, P. D. Drooling. J. Oral Pathol

Med 2009; 38: 321-7.

3. Meece RW, Fishlock KF, Bayley EW, Keller MS. Ultrasound-Guided

Botox Injections of Salivary Glands in Children with Drooling. J

Radiol Nursing 2010; 29: 20-4.

4. Reid SM, Johnson HM, Reddihough DS. The Drooling Impact

Scale: a measure of the impact of drooling in the children with

developmental disabilities. Develop Med & Child Neurol 2010;

52: e23-8.

5. Hockstein N, Samadi D, Gendron K, Handler S. Sialorrhea: A

Management Challenge. Am Fam Physic 2004; 69: 2628-34.

6. Erasmus C, Van Hulst K, Rotteveel L, et al. Drooling in cerebral

palsy: Hypersalivation or dysfunctional oral motor control? Develop

Med & Child Neurol 2009; 51: 454-9.

7. Banerjee K, Glasson C, O’Flaherty S. Parotid and submandi-

bular botulinum toxin A injections for sialorrhoea in children

with cerebral palsy. Develop Med & Child Neurol 2006; 48:

883-7.

8. van der Burg J, Jongerius P, van Hulst K, van Limbeek J, Rotteveel

J. Droling in children with cerebral palsy: effect of salivary flow

reduction on daily life and care. Develop Med & Child Neurol

2006; 48: 103-7.

9. Scheffer A, Erasmus C, van Hulst K, van Limbeek J, Jongerius P, van

den Hoogen F. Efficacy and Duration of Botulinum Toxin Treatment

for Drooling in 131 Children. Arch Otolaryngol Head Neck Surg

2010; 136: 873-7.

10. Benson J, Daugherty K. Botulinum Toxin A in the Treatment of

Sialorrhea. The Ann Pharma 2007; 41: 79-85.

11. Laing TA, Laing ME, O’Sullivan ST. Botulinum Toxin for treatment

of glandular hypersecretory disorders. J Plastic Reconstr & Anesth

Surg 2008; 61: 1024-8.

12. Van der Burg J, Didden R, Jongerius P, Rotteveel J. A descriptive

analysis of studies on behavioural treatment of drooling (1970-

2005). Develop Med & Child Neurol 2007; 49: 390-4.

13. Bachrach S, Walter R, Trzcinski K. Use of glycopyrrolate and other

anticholinergic medications for sialorrhea in children with cerebral

palsy. Clin Pediatrics 1998; 37: 485-90.

14. Jongerius P, van Tiel P, van Limbeek J, Gabreels FJ, Rotteveel J. A

systematic review for evidence of efficacy of anticholinergic drugs

to treat drooling. Arch Dis Child 2003; 10: 911-4.

15. Winterholler M. Treatment of sialorrhea in patients under long-

term ventilation. Pneumologie 2008; 62(Suppl 1): S39-42.

16. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C, Beuche

W. Botulinum toxin to reduce saliva flow: selected indications

for ultrasound-guided toxin application into salivary glands.

Laryngoscope 2002; 112:82-6.

17. Little S, Kubba H, Hussain S. An evidence-based approach to the

child who drools saliva. Clin Otolaryngol 2009; 34: 236-9.

Neumol Pediatr 2012; 7 (1): 13-18

Sialorrea neurogénica infantil y el manejo con la toxina Botulínica - S. Chahuán et al.